[Aplastic anemia--contemporary procedures and therapeutic perspectives]. / Anemia aplastyczna--wspólczesna diagnostyka, mozliwosci oraz perspektywy terapeutyczne.
Przegl Lek
; 56(7-8): 506-14, 1999.
Article
em Pl
| MEDLINE
| ID: mdl-10575919
ABSTRACT
Severe aplastic anaemia (SAA) state of art is summarised. Currently there are two therapeutic possibilities allogeneic bone marrow transplantation (BMT) and immunosuppressive therapy. Decision should be based on disease severity, patient performance status, age and the availability of the HLA identical donor. Allogeneic BMT is the treatment of choice for the young (less than 25 years) SAA patients. It's side effects including graft versus host disease markedly increase with age. Immunosuppressive therapy is an option for patients older than 45, or younger ones with no HLA compatible donor. Optimisation of the treatment protocols is the subject of various ongoing randomised multicentre studies.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Anemia Aplástica
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Prognostic_studies
Limite:
Adult
/
Aged
/
Humans
/
Middle aged
Idioma:
Pl
Revista:
Przegl Lek
Ano de publicação:
1999
Tipo de documento:
Article